MedSIR

Quick facts

Phase 3 pipeline

• Auxiliary Medicinal Product - Dexamethasone · Immunology / Oncology (supportive care)
  Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Phase 2 pipeline

• Niraparib oral tablets

Phase 1 pipeline

• Debio 0123 and Sacituzumab govitecan

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• MedSIR portfolio CI brief
• MedSIR pipeline updates RSS